Alchemab Therapeutics at PEGS Europe 2026

Nov 16–19, 2026 Lisbon, Portugal ~1.5k attendees Website

Alchemab Therapeutics brings 2 presentations to PEGS Europe 2026 in Lisbon. Its contribution covers antibodies drawn from people who resist disease, including one against the prostaglandin pathway with potential in Parkinson's disease.

OrganizationPEGS Europe 2026 Attendance
alchemab.com
Biotech
Finds therapeutic antibodies by studying the antibody repertoires of people resilient to disease.
Chair
Thu Nov 19
2:00pm–2:05pm
Chairperson’s Remarks
Antibodies Against Challenging Targets
Talk
Thu Nov 19
4:15pm–4:45pm

Explore the full PEGS Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Lisbon. Leave your work email and we’ll be in touch.

Privacy

Download the full PEGS Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Alchemab Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by PEGS Europe or its organizers. Submit a correction